These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2866970)

  • 21. SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.
    Carboni E; Longoni R; Deidda S; Di Chiara G
    Eur J Pharmacol; 1986 Jun; 125(1):17-22. PubMed ID: 3525197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
    Ushijima I; Mizuki Y; Yamada M
    Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
    Biała G
    Acta Pol Pharm; 2000; 57(3):233-7. PubMed ID: 11143713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice.
    Chinen CC; Frussa-Filho R
    Neuropsychopharmacology; 1999 Nov; 21(5):670-8. PubMed ID: 10516963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dopamine D-1 and D-2 antagonists on decision making by rats: no reversal of neuroleptic-induced attenuation by scopolamine.
    Ljungberg T; Enquist M
    J Neural Transm Gen Sect; 1990; 82(3):167-79. PubMed ID: 1979001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.
    Erzin-Waters C; Muller P; Seeman P
    Can J Physiol Pharmacol; 1976 Aug; 54(4):516-9. PubMed ID: 10058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    Mandhane SN; Chopde CT; Ghosh AK
    Eur J Pharmacol; 1997 Jun; 328(2-3):135-41. PubMed ID: 9218695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not.
    Fowler SC; Liou JR
    Psychopharmacology (Berl); 1998 Nov; 140(1):81-90. PubMed ID: 9862406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats.
    Mehta AK; Ticku MK
    Life Sci; 1990; 46(1):37-42. PubMed ID: 2153885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
    Bardin L; Kleven MS; Barret-Grévoz C; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1869-79. PubMed ID: 16237379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats.
    Rowlett JK; Pedigo NW; Bardo MT
    Pharmacol Biochem Behav; 1991 Dec; 40(4):829-34. PubMed ID: 1840081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
    Klemm WR; Block H
    Pharmacol Biochem Behav; 1988 Feb; 29(2):223-9. PubMed ID: 3283778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrimination of morphine- and haloperidol-induced muscular rigidity and akinesia/catalepsy in simple tests in rats.
    Fischer DA; Ferger B; Kuschinsky K
    Behav Brain Res; 2002 Aug; 134(1-2):317-21. PubMed ID: 12191819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
    Lee J; Rushlow WJ; Rajakumar N
    Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.